The new year arrived with a ton of momentum for those in the Cystic Fibrosis Foundation community, as the FDA approved a new drug named “Trikafta” in October 2019. Trikafta is a triple combination therapy that will ultimately treat about 90% of the CF population and generally had very positive results during its clinical trial stage.
The goal of therapies like Trikafta are to relieve symptoms and potentially IMPROVE quality of life, as those with CF continue to fight day in and day out for the opportunity to lead self-fulfilling lives.
Though therapy combinations may not have the same effects on each individualized case, the approval of breakthrough treatments give everyone within the CF community HOPE. Hope that hard work leads to individual health improvements. Hope that family members and friends see their loved one’s quality of life improve. Hope for those with CF who may not be able to take this specific new drug because they know we are getting closer to the next advancement. Hope for all people that are or have been affected by cystic fibrosis, as we grasp the significance of being one step closer to a cure.
Essential research and development of new therapies such as Trikafta are possible because of YOUR SUPPORT. Great Strides teams, such as JohnnyP’s Crew, are proof that incredible things can happen when we work together. Please save the date (Saturday, May 16, 2020), donate if you are able and/or sign up to walk with us in Verona, NJ this spring.
Thank you, as always, for your continued support!